Four years intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

被引：0
|
作者：
Lamy, O [1 ]
Sandini, L [1 ]
Burnand, J [1 ]
Krieg, MA [1 ]
Burckhardt, P [1 ]
机构：
[1] Univ Lausanne Hosp, Lausanne, Switzerland
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
491
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [21] EFFICIENCY AND SAFETY OF IBANDRONATE IN TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
    Gojkovic, F.
    Vasic, J.
    Elez, J.
    Vojinovic, V. Culafic
    Zvekic-Svorcan, J.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S169 - S169
  • [22] Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
    Sambrook, Philip
    CLINICAL INTERVENTIONS IN AGING, 2007, 2 (01): : 65 - 72
  • [23] Ibandronate: An IV injection for the treatment for postmenopausal osteoporosis
    Rizzoli, Rene
    Reid, David M.
    BONE, 2007, 41 (05) : S24 - S28
  • [24] Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: A comprehensive review
    Reginster, JY
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) : 3711 - 3728
  • [25] Two-year efficacy and tolerability of intermittent intravenous ibandronate injections in postmenopausal osteoporosis: the DIVA study.
    Emkey, R
    Zaidi, V
    Lewiecki, EM
    Burdeska, A
    Mairon, N
    Rowell, L
    Eisman, JA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4060 - 4060
  • [26] Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study
    Eisman, John A.
    Civitelli, Roberto
    Adaml, Silvano
    Czerwinski, Edward
    Recknor, Chris
    Prince, Richard
    Reginster, Jean-Yves
    Zaidi, Mone
    Felsenberg, Dieter
    Hughes, Claire
    Mairon, Nicole
    Masanauskaite, Daiva
    Reid, David M.
    Delmas, Pierre D.
    Recker, Robert R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 488 - 497
  • [27] Efficacy and Tolerability of Intravenous Ibandronate Injections in Postmenopausal Osteoporosis: 2-Year Results from the DIVA Study
    Mikosch, P.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (03): : 159 - +
  • [28] Intravenous ibandronate in the treatment of osteoporosis - Profile report
    Croom, Katherine F.
    Scott, Lesley J.
    DRUGS & AGING, 2006, 23 (12) : 997 - 1001
  • [29] Treatment of corticoid-induced osteoporosis by 3-monthly intravenous ibandronate injections.
    Ringe, JD
    Cöster, A
    Dorst, A
    Umbach, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S150 - S150
  • [30] Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
    Recker, Robert R.
    Ste-Marie, Louis-George
    Langdahl, Bente
    Czerwinski, Edward
    Bonvoisin, Bernard
    Masanauskaite, Daiva
    Rowell, Lucy
    Felsenberg, Dieter
    BONE, 2010, 46 (03) : 660 - 665
12345